Evidence map›Paper›PMID 32443776›Full record

ReviewInternational journal of molecular sciences2020

The Role of Autophagy for the Regeneration of the Aging Liver.

Fengming Xu, Chuanfeng Hua, Hans-Michael Tautenhahn, Olaf Dirsch, Uta Dahmen

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. The EPMA journal · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Fengming XuDepartment of General, Visceral and Vascular Surgery, Jena University Hospital, 07747 Jena, Germany.
Chuanfeng HuaDepartment of General, Visceral and Vascular Surgery, Jena University Hospital, 07747 Jena, Germany.
Hans-Michael TautenhahnDepartment of General, Visceral and Vascular Surgery, Jena University Hospital, 07747 Jena, Germany.
Olaf DirschInstitute of Pathology, Klinikum Chemnitz gGmbH, 09111 Chemnitz, Germany.
Uta DahmenDepartment of General, Visceral and Vascular Surgery, Jena University Hospital, 07747 Jena, Germany.
Jena University Hospital · DEKlinikum Chemnitz · DE

Funding

Else Kröner-Fresenius-Stiftung Jena School for Ageing Medicine (JSAM)
6 · The paper itself

Abstract

Age is one of the key risk factors to develop malignant diseases leading to a high incidence of hepatic tumors in the elderly population. The only curative treatment for hepatic tumors is surgical removal, which initiates liver regeneration. However, liver regeneration is impaired with aging, leading to an increased surgical risk for the elderly patient. Due to the increased risk, those patients are potentially excluded from curative surgery. Aging impairs autophagy via lipofuscin accumulation and inhibition of autophagosome formation. Autophagy is a recycling mechanism for eukaryotic cells to maintain homeostasis. Its principal function is to degrade endogenous bio-macromolecules for recycling cellular substances. A number of recent studies have shown that the reduced regenerative capacity of the aged remnant liver can be restored by promoting autophagy. Autophagy can be activated via multiple mTOR-dependent and mTOR-independent pathways. However, inducing autophagy through the mTOR-dependent pathway alone severely impairs liver regeneration. In contrast, recent observations suggest that inducing autophagy via mTOR-independent pathways might be promising in promoting liver regeneration. Conclusion: Activation of autophagy via an mTOR-independent autophagy inducer is a potential therapy for promoting liver regeneration, especially in the elderly patients at risk.

Indexed as

AutophagyLiver RegenerationAgingAnimalsHumansLiverAMPKhepatectomyhepatocytemTORproliferationTFEBULK1

Identifiers

PMID32443776
PMCPMC7279469
OpenAlexW3027045245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.